Dr. Kayvan R. Keshari received degrees in Biochemistry, Mathematics and Biomedical Engineering from the University of California, Berkeley and University of North Carolina, respectively, after which he completed postdoctoral training at the University of California, San Francisco (UCSF) in Biomedical imaging and Bioengineering under the supervision of Dr. John Kurhanewicz. He is currently an Associate Member (Associate Professor) and Laboratory Head at Memorial Sloan Kettering Cancer Center, with appointments in both the Department of Radiology and the Molecular Pharmacology Program. He is a professor in the Gerstner Sloan Kettering School of Biomedical Sciences and in multiple departments at Cornell University including Chemical Biology, Biophysics and Biochemistry. At MSK, Dr. Keshari’s lab focuses on the interrogation of metabolic processes and advanced multi-modality imaging. With changes in cancer metabolism as the driving force, the lab’s biochemical investigation is centered on oxidative stress and changes in redox, as well as the rates of biochemical reactions, which underlie fundamental cancer biology, drive aggressiveness and response to therapeutics. The long-term goal is to leverage these novel mechanisms to better understand disease and develop new therapeutic strategies.

Arend Heerschap is emeritus professor in Biomedical MR at the Radboud University Medical Centre Nijmegen, the Netherlands. In his research he is interested in the unique capabilities of MR imaging and MR spectroscopy to study molecular and biological processes in humans and animal models. More specifically his research addresses fundamental biomedical questions and clinical problems in oncology and intermediate (energy-) metabolism. The studies mainly focused on prostate, brain, liver, and skeletal muscle.

Dr. Stanisz’ research is in the area of Magnetic Resonance Imaging (MRI) He is an internationally renowned expert in the field of quantitative MRI. He is an author of 140 scientific papers which provide basic understanding of the MRI contrast mechanisms in tissues such as magnetization transfer, relaxometry, CEST and diffusion.

Dr. Marty Pagel has focused on molecular imaging research during the last 20 years in industry and academia. He is a Professor in the Departments of Cancer Systems Imaging and Imaging Physics at the University of Texas MD Anderson Cancer Center. In addition, Dr. Pagel has held leadership positions in professional societies, funding agencies, and scientific journals that focus on molecular imaging. Dr. Pagel’s current research focuses on CEST MRI, DCE MRI, PET/MRI, and photoacoustic imaging, for studies with mouse models of cancer and for clinical trials with cancer patients.